Rehabilitation Program on Genetic and Degenerative Ataxia
NCT ID: NCT06089863
Last Updated: 2024-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
48 participants
INTERVENTIONAL
2024-02-01
2027-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These symptoms cause a decrease in the quality of life on patients with spinocerebellar ataxia. The symptoms improvement linked to the cerebellar syndrome is based on rehabilitation that can be supplemented by use of technical aids. Current scientific knowledge confirms that intensive rehabilitation by physiotherapy and occupational therapy in patients with degenerative ataxias improves cerebellar symptoms. Nevertheless, the choice rehabilitation technique stay at the appreciation of the therapist.
From the observation, the investigators have designed an intensive multidisciplinary rehabilitation program, called PAMPERO, with partner patients member of two genetic degenerative ataxia patient organisations. This 5-weeks program has been used in clinic during 3 years on 28 patients. It appears to be the only one in France.
The preliminary results show a positive effect on ataxia symptom. Nevertheless, the duration of the benefice over time and the effect on the quality of life stay unknown.
However, the quality of life is mainly affected by the participation restriction due to the risk of falling. The most frequent complaint from partner patient is the diminution of the social interaction resulting of the incapacity to move without risk.
The present protocol aimed at evaluating the Rehabilitation Program in collaboration with partner patient on the symptom intensity, activity and quality of life on genetic and degenerative ataxia.
This PAMPERO program's effect will be assessed by comparing the difference of Intensity of symptom measured by to Scale for the Assessment and Rating of Ataxia (SARA) at inclusion and 3 months after the end of rehabilitation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Empowerment Aging and Disability (HEAD): New Technologies for Neurorehabilitation
NCT03025126
Neuralgic Amyotrophy: Central Reorganization and Rehabilitation After Peripheral Dysfunction
NCT03441347
Mirror Therapy Rehabilitation for Motor Functional Neurological Disorders.
NCT04739176
Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis
NCT02960984
Interdisciplinary Home Rehabilitation of Patients With Stroke. A Randomised Controlled Intervention Trial.
NCT00626353
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PAMPERO program group
This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity.
PAMPERO program
This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity. The duration of this program is 5 weeks and each week is divided as follow :
* 5 hours of physical therapy : individual session with the objective to improve the dynamic balance and coordination on the aim to gain confidence of moving, gripping capacity and interaction with object
* 5 hours of Adapted Physical activity : group session to promote pairing with muscle building priority
* 1 hour of Speech therapy : group session to educate and promote prevention strategy about dysphagia rick
* 2 hours of Occupational therapy : group session to bring adaptive solution of autonomy lost with material propose, home organisation or gesture
* 2 hours of Hydrotherapy : group session activity performed in water to assist rehabilitation
Usual Care intervention group
Usual Rehabilitation of the patient after the inclusion. 0 to 2 physical therapy sessions and 0 to 2 Speech therapy sessions each week usually constitute this program.
This rehabilitation highly depends on the patients usual preferences. Some patients have no rehabilitation in the daily care while some have more.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PAMPERO program
This program is an intensive multidisciplinary program rehabilitation including Physical, Occupational, Speech, Psychomotor therapy and Adapted Physical Activity. The duration of this program is 5 weeks and each week is divided as follow :
* 5 hours of physical therapy : individual session with the objective to improve the dynamic balance and coordination on the aim to gain confidence of moving, gripping capacity and interaction with object
* 5 hours of Adapted Physical activity : group session to promote pairing with muscle building priority
* 1 hour of Speech therapy : group session to educate and promote prevention strategy about dysphagia rick
* 2 hours of Occupational therapy : group session to bring adaptive solution of autonomy lost with material propose, home organisation or gesture
* 2 hours of Hydrotherapy : group session activity performed in water to assist rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with genetic and degenerative cerebellar ataxia
* Diagnostic of cerebellar ataxia confirmed by anatomic MRI
* Affiliated to a social insurgence regime or similar
* Patients who have given their free, informed and express consent
* Walking patients (who can walk unsupervised on flat ground with the help of proper technique : categories greater than 4 on the New Functional Ambulation Classification scale)
* Patients who have already benefited from a hospitalization of more than 3 weeks for rehabilitation during the last 12 months
* Patients participating simultaneously in another research whose objective would be the evaluation of a therapy, medicinal or not, likely to improve neurological or functional recovery
* Pregnants, parturient or breastfeeding
* Patients deprived of their liberty by a judicial or administrative decision
* Psychiatric care patients
* Patients admitted to Patients admitted to a health or social establishment for purposes other than research for purposes other than research
* Major patients protected by the Law
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Rééducation Fonctionnelle (S.S.R.) Val Rosay
Saint-Didier-au-Mont-d'Or, , France
Service de Médecine Physique et Réadaptation (M.P.R) de l'Hôpital Bellevue
Saint-Etienne, , France
Service de Rééducation Fonctionnelle (S.S.R.) de l'Hôpital Henry Gabrielle Hospices Civils de Lyon
Saint-Genis-Laval, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0912
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.